← Back to Search

Split-belt treadmill training for Freezing of Gait

N/A
Recruiting
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Idiopathic PD
Disease duration: 5-15 years
Timeline
Screening 3 weeks
Treatment Varies
Follow Up obtained at baseline evaluation, after 1.5 months of training, and 3-months post intervention
Awards & highlights

Study Summary

This trialinvestigates if a split-belt treadmill can reduce gait and balance impairments in Parkinson's disease sufferers, potentially improving quality of life.

Eligible Conditions
  • Gait Instability
  • Freezing of Gait
  • Parkinson's Disease

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You have Parkinson's disease with no known cause.
Select...
You have had the disease for at least 5 years, but no longer than 15 years.
Select...
You are able to walk on a treadmill that moves on its own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~obtained at baseline evaluation, after 1.5 months of training, and 3-months post intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and obtained at baseline evaluation, after 1.5 months of training, and 3-months post intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Falls
Secondary outcome measures
Balance and postural stability
Freezing of gait
Gait
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
The velocity of the belt will be adjusted to the over-ground speed of the subject, and will be reduced on the least affected side by 25%. While the speed of the treadmill will not change throughout the study, the duration of the training will increase each week. In the first week, the SBTM training will take place for 10 minutes. There will be a 5-minute rest period, and the split-belt conditions will continue for another 10 minutes of training (total training time= 20 minutes).
Group II: Control groupActive Control1 Intervention
The subject will continue to walk under tied-belt conditions adjusted to the over-ground walking speed. In the first week, the treadmill training will be for 10 minutes. They will get a 5-minute break, similar to the intervention group, and continue for another 10 minutes under tied-belt conditions. The duration of each session will increase by 8 minutes every week. For example, in week 1, the treadmill training will be for a total of 20 minutes; in week 2, for 28 minutes; in week 3, for 36 minutes, and so forth, until it gets to 60 minutes by week 6. The rest period will remain at 5 minutes each session, and will always take place at the halfway mark. All 3 sessions in the week will have the same duration of training. If the subject cannot tolerate the velocity or duration of the session, the protocol will be adjusted to most recently tolerated session (and will be recorded for further interpretation and analysis).

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
687 Previous Clinical Trials
1,018,267 Total Patients Enrolled
1 Trials studying Freezing of Gait
20 Patients Enrolled for Freezing of Gait

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are being considered for inclusion in this research endeavor?

"Affirmative. According to the records on clinicaltrials.gov, this research project is actively seeking patients and was first listed on March 27th 2020. The most recent update came in November 1st 2022 with a target of 28 participants from one site."

Answered by AI

Are researchers currently seeking participants for this trial?

"Affirmative. The trial, which was first advertised on March 27th 2020, is currently inviting eligible participants to apply. Only 28 patients from a single site are needed for this medical study."

Answered by AI
~6 spots leftby Mar 2025